InvestmentUpdated on 8 January 2026
Rebooting the immune system.
Founder / CEO at Reboot
Woerdense Verlaat, Netherlands
About
Our Hsp70-based treatment reverses immunoparalysis - a condition where the immune system shuts down after severe injury - without the limitations of current approaches that suppress T-cell function. With 30% of ICU deaths attributed to hospital-acquired infections in immune-compromised patients, we address a €2B+ market with no approved therapies. We are seeking seed funding to complete preclinical validation and secure European Defence Fund co-financing for military trauma applications. More info: rebootsciences.com
Organisation
Similar opportunities
Product
Intensive Care unit for use in aircraft - install in under 2 hours
Rogier van Beugen
CEO at Inflight ICU
Amsterdam, Netherlands
Product
Guus Basstein
Senior Account Executive at Geurtsen Defence
Deventer, Netherlands
Product
VRbio – Biometric VR for Human Performance & Simulation
- ICT
- Biotech and Lifescience
Averell van den Bos
Owner at SkillTransmission
Rotterdam, Netherlands